Jupiter Neurosciences, Inc. (JUNS)
3.06
-0.03
(-0.97%)
USD |
NASDAQ |
Sep 10, 16:00
3.08
+0.02
(+0.65%)
After-Hours: 20:00
Jupiter Neurosciences Total Assets (Quarterly) : 3.719M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.719M |
| March 31, 2026 | 3.949M |
| December 31, 2025 | 5.564M |
| September 30, 2025 | 2.576M |
| June 30, 2025 | 3.968M |
| March 31, 2025 | 4.963M |
| December 31, 2024 | 6.202M |
| September 30, 2024 | 0.1605M |
| June 30, 2024 | 0.2118M |
| March 31, 2024 | 0.1168M |
| Date | Value |
|---|---|
| December 31, 2023 | 0.1486M |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | 0.2359M |
| September 30, 2022 | 0.4461M |
| June 30, 2022 | 0.8073M |
| March 31, 2022 | 0.4042M |
| December 31, 2021 | 0.6674M |
| September 30, 2021 | 1.759M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Johnson & Johnson | 201.06B |
| Jaguar Health, Inc. | 34.19M |
| Atai Beckley, Inc. | 264.79M |
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.085M |
| Shareholders Equity (Quarterly) | -0.366M |
| Debt to Equity Ratio | -4.852 |
| Current Ratio | 0.657 |
| Net Debt Paydown Yield | -2.94% |